Comparative activities of three new antibacterial agents with aztreonam against gram-negative bacilli.
Kafetzis
D A
DA
2nd Dept. of Pediatrics, University of Athens, Aglaïa Kyriakou Children's Hospital, Greece.
Legakis
N J
NJ
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001398:Aztreonam / Q000031:analogs & derivatives* / Q000494:pharmacology*; D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000494:pharmacology; D002939:Ciprofloxacin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004359:Drug Therapy, Combination / Q000494:pharmacology; D004755:Enterobacteriaceae / Q000187:drug effects*; D016576:Fleroxacin; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D008826:Microbial Sensitivity Tests / Q000379:methods; D011550:Pseudomonas aeruginosa / Q000187:drug effects*
D000900:Anti-Bacterial Agents; C044145:carumonam; D002939:Ciprofloxacin; D015296:Ceftizoxime; C047445:cefetamet pivoxyl; D001398:Aztreonam; D016576:Fleroxacin